Location History:
- Upminster, EN (1976)
- Ilkley, EN (1976 - 1977)
Company Filing History:
Years Active: 1976-1977
Title: **Innovative Contributions of Bryan John Large**
Introduction
Bryan John Large is a distinguished inventor based in Ilkley, GB, known for his significant contributions to pharmacology through his inventions. With a total of four patents to his name, Large has focused on developing novel compounds aimed at addressing critical health issues, particularly allergic respiratory disorders.
Latest Patents
Among his latest inventions are the 8-Azapurin-6-ones, which are substituted in the 2-position by a phenyl group that carries a sulfonamide substituent in a meta-position. This compound, along with pharmacologically acceptable salts, is designed to provide therapeutic benefits, particularly in the treatment of allergic bronchial asthma. Another notable patent involves certain novel 8-azapurin-6-one derivatives that are preferentially substituted by an alkoxy group in the 2-position. These derivatives exhibit valuable pharmacological properties that are expected to be crucial in treating respiratory disorders caused by the interaction of tissue-fixed antibodies with specific antigens.
Career Highlights
Bryan John Large has established himself as a pivotal figure at May & Baker, Ltd., where he has been instrumental in advancing research and development of innovative pharmaceutical solutions. His work has not only contributed to the scientific community but has also enhanced the company’s reputation for cutting-edge therapies.
Collaborations
Throughout his career, Large has had the opportunity to collaborate with talented professionals, including Barbara Joyce Broughton and Stuart Malcolm Marshall. These collaborations have fostered an environment of innovation and synergy, leading to groundbreaking discoveries that have the potential to impact many lives positively.
Conclusion
In summary, Bryan John Large's innovative contributions to pharmacology highlight the importance of research and development in addressing health challenges. His patents signify not only personal achievement but also a collective advancement in medical therapies that hold promise for the treatment of various allergic respiratory conditions. As he continues to push the boundaries of innovation, his work remains a valuable asset to the field.